LTF and neuroblastoma: The present study investigated the potential of lactoferrin to inhibit the proliferation of IMR-32 human neuroblastoma cells compared to doxorubicin and dibutyryl cyclic AMP (db-cAMP), including under X-ray irradiation conditions.